The Efficacy and Safety of Fractional CO<sub>2</sub> Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation: A Randomized Controlled Split-Face Study

<div>Representative clinical photographs: (a, c) baseline, (b) 12 weeks after the BTX-A + fractionated CO<sub>2</sub> laser treatment, and (d) 12 weeks after the saline solution + fractionated CO<sub>2</sub> laser treatment.</div>

BioMed Research International

fig1

Figure 1

Figure 1: The Efficacy and Safety of Fractional CO<sub>2</sub> Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation: A Randomized Controlled Split-Face Study 

Figure 1 | The Efficacy and Safety of Fractional CO2 Laser Combined with Topical Type A Botulinum Toxin for Facial Rejuvenation: A Randomized Controlled Split-Face Study 